Login

Financial Snapshot

Revenue
TTM
$2.144B
Gross Margin
TTM
23.99%
Net Income
TTM
-$14.19M
Current Assets
2026 Q1
Current Liabilities
2026 Q1
Current Ratio
2026 Q1
116.54%
Total Assets
2026 Q1
Total Liabilities
2026 Q1
Book Value
2026 Q1
$1.353B
Cash
2026 Q1
P/E
Last 4 Quarters
N/A
Free Cash Flow
TTM
$102.0M

Stock Price

Loading...
Market Cap: $4.2706 Billion

About RadNet Inc

RadNet Inc (NASDAQ: RDNT) is a diagnostic imaging services company that owns and operates outpatient imaging centers across the United States. Revenue is generated through fee-for-service billings to third-party payors and through capitation arrangements, with service fee revenue representing 93.8% of total service revenue and capitation arrangements 6.2% in FY2025. RadNet's centers are organized into regional networks concentrated in major population centers across nine states, competing against hospitals and other outpatient imaging operators by offering multi-modality services at a single location at fees generally below hospital rates. The company also operates a Digital Health segment, which generated $92.7 million in revenue in FY2025 against $65.7 million in FY2024, focused on AI-enabled radiology workflow products including clinical AI for mammography, lung, prostate, and ultrasound imaging, plus enterprise products such as RIS, PACS, and remote scanning solutions. RadNet carries significant debt, with total term loan carrying value of approximately $1.07 billion as of December 31, 2025, and total future contractual obligations of approximately $2.56 billion.

Revenue model
Fee-for-service billings to managed care and other third-party payors (93.8% of service revenue in FY2025) plus capitation arrangements (6.2% of service revenue in FY2025). Digital Health segment revenue is transactional and subscription-based, generated from AI software and enterprise imaging products sold to outpatient and hospital radiology customers.
Products and services
Multi-modality diagnostic imaging services including MRI, CT, PET, mammography, ultrasound, and related procedures offered at outpatient centers. Digital Health segment products include clinical AI tools for mammography, lung, prostate, and ultrasound imaging (developed through acquisitions of DeepHealth, Aidence, Quantib, Kheiron Technologies, ICAD Inc, See Mode Technologies, and CIMAR), plus enterprise products: RIS, PACS, Reporting, and a Remote Scanning Solution.
Customers and end markets
Patients referred by physicians for outpatient diagnostic imaging. Revenue is substantially dependent on contracted radiology groups that hold managed care contracts. Payors include managed care organizations under both fee-for-service and capitation arrangements. The Digital Health segment sells to outpatient radiology practices and hospitals.
Value-chain role
Outpatient diagnostic imaging services operator and radiology workflow technology provider. Sits between referring physicians and hospital systems, providing lower-cost imaging alternatives. Contracts with independent radiology groups to provide medical services at its centers under management agreements.
Geographic exposure
Nine U.S. states, concentrated in major population centers, as disclosed in the 10-K filed 2026-03-02.

Source: SEC 10-K, filed 2026-03-02

Industry: Services-Medical Laboratories Peers: Accolade, Inc. Cross Country Healthcare Inc CVS Health Corp DocGo Inc P3 Health Partners Inc Fulgent Genetics Inc Hims & Hers Health Inc InnovAge Holding Corp National Research Corp

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support